Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum DiaMedica Therapeutics Inc DMAC

DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in... see more

NDAQ:DMAC - Post Discussion

DiaMedica Therapeutics Inc > Stock price could hit $5.00US by end of week.
View:
Post by StockscoutX on Mar 25, 2019 2:44pm

Stock price could hit $5.00US by end of week.

I think there is some anticipation building up with this stock going forward. If there was any bad news behind the scene it would have already impacted the SP to continue downward. IMO.
Comment by joelou on Mar 25, 2019 7:53pm
I agree.  Seems to be good support at $4.  Hopefully the trend continues!! maybe we are going to get a news release regarding the Chinese registered trial.  Cheers. JL
Comment by Pugsrock2 on Mar 29, 2019 7:14pm
Not 5$ but I will take.
Comment by Pugsrock2 on Apr 10, 2019 7:05pm
Not even 5$ CAD. PATHETIC. Sitting here on the market makers yoyo. Some news someday might be helpful
Comment by Pandora on Apr 10, 2019 10:25pm
I was surprised at the timing of their move to the Nasdaq. I thought it might be timed around an event that would bring some recognition to the progress they are making but not the case. Here we are 3 months later and although they have a couple of news releases there is nothing that is attracting good attention to their potential. So it seems their financing was off and their timing was off.
Comment by TrueNorth911 on Apr 10, 2019 11:24pm
Early is how I would characterize it.... but don't forget they were under immense pressure to raise funds to continue the trials, and to kick-off CKD trials.... and we all know that was NOT going to happen in Canada on TSX-V. No way they were going to raise $20M Cdn! in Canada. Be real. I know it sounds like a broken record...but it needs to play itself out.  We're still early in the ...more  
Comment by Pugsrock2 on Apr 11, 2019 8:57pm
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities